Drug delivery systems are increasingly popular platforms that are used for a specific purpose – these are systems that allow for so-called encapsulation. This is precise delivery of active substances to the body. A very good example of a company that specializes in delivery systems is Syvento – specialists in this company work based on lipid nanoparticles and liposomes, which protect the drug and increase its effectiveness. If you have an idea for drugs and want to encapsulate it, creating a unique product, this company is the right direction.
- Development of encapsulated drugs – how are modern drugs created?
- Innovations in the development of LNP technology
Thanks to modern delivery systems, which are based on LNP, i.e. lipid nanoparticles (LNP) and liposomes, you can be sure that drug transport is possible through cell membranes. Thanks to this, drugs are much more bioavailable and effective in action. Read on to find out more!
Development of encapsulated drugs – how are modern drugs created?
The creation of modern drugs can be divided into different stages – the first is the development of modern forms, in which the drug is encapsulated inside a lipid structure. This is a very modern approach, which significantly increases the protection of the particle against degradation in the body, but not only that – it also enables controlled release of the substance.
In drug delivery systems, the role of lipid-based delivery systems is very important. What is it about? It is best explained based on the SyVento delivery platform. The company is a leader when it comes to such solutions – it uses lipid carriers, i.e. liposomes and lipid nanoparticles – to create a delivery system. The goal in this case is very specific – they are to enable the transport of both nucleotides and small molecules, proteins or peptides.
This approach means that drugs are delivered to the body precisely, and side effects are minimized.
Innovations in the development of LNP technology
We have been observing the development of liposomes, up to advanced LNPs, since the 1960s. It is thanks to this development that such great progress is possible in terms of the development of drug delivery. It would not be an exaggeration to say that when it comes to ionized lipids, a very large improvement is visible in terms of the stability and efficiency of RNA transport.
All thanks to surface modification – through antibodies, aptamers or ligands, targeted applications are possible. The effectiveness of treatment is increased thanks to drug release, i.e. controlled release of the drug. The particles simply penetrate specific tissues or cells.
The potential of the SyVento platform is huge – through solutions such as future drug delivery, we can today, among others, treat genetic diseases or create vaccines. Check on https://syvento.com/our-services/delivery-platform/ if you want to know more!